skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [2];  [1];  [2];  [3];  [2];  [1];  [4]; ORCiD logo [5]; ORCiD logo [5];  [5];  [3];  [1];  [6];  [1]
  1. Boston Children's Hospital, Boston, MA (United States); Harvard Medical School, Boston, MA (United States)
  2. GlaxoSmithKline Vaccines, Rockville, MD (United States)
  3. Beth Israel Deaconess Medical Center, Boston, MA (United States)
  4. Codex BioSolutions, Inc., Gaithersburg, MD (United States)
  5. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  6. GlaxoSmithKline Vaccines, Rockville, MD (United States); Valera LLC, Cambridge, MA (United States)

Here, the extraordinary genetic diversity of the HIV-1 envelope spike [Env; trimeric (gp160)3, cleaved to (gp120/gp41)3] poses challenges for vaccine development. Envs of different clinical isolates exhibit different sensitivities to antibody-mediated neutralization. Envs of difficult-to-neutralize viruses are thought to be more stable and conformationally homogeneous trimers than those of easy-to-neutralize viruses, thereby providing more effective concealment of conserved, functionally critical sites. In this study we have characterized the antigenic properties of an Env derived from one of the most neutralization-resistant HIV-1 isolates, CH120.6. Sequence variation at neutralizing epitopes does not fully account for its exceptional resistance to antibodies. The full-length, membrane-bound CH120.6 Env is indeed stable and conformationally homogeneous. Its antigenicity correlates closely with its neutralization sensitivity, and major changes in antigenicity upon CD4 engagement appear to be restricted to the coreceptor site. The CH120.6 gp140 trimer, the soluble and uncleaved ectodomain of (gp160)3, retains many antigenic properties of the intact Env, consistent with a conformation close to that of Env spikes on a virion, whereas its monomeric gp120 exposes many nonneutralizing or strain-specific epitopes. Thus, trimer organization and stability are important determinants not only for occluding many epitopes but also for conferring resistance to neutralization by all but a small set of antibodies. Env preparations derived from neutralization-resistant viruses may induce irrelevant antibody responses less frequently than do other Envs and may be excellent templates for developing soluble immunogens.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
Universities/Institutions; USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1374321
Report Number(s):
LA-UR-16-29058
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 17; ISSN 0027-8424
Publisher:
National Academy of Sciences, Washington, DC (United States)Copyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 13 works
Citation information provided by
Web of Science

References (40)

Structure of the transmembrane domain of HIV ‐1 envelope glycoprotein journal November 2016
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies journal March 2008
Atomic structure of the ectodomain from HIV-1 gp41 journal May 1997
Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation journal July 2012
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G journal May 2016
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions journal October 2014
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env journal September 2015
Viral membrane fusion journal July 2008
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans journal May 2013
Structural basis for membrane anchoring of HIV-1 envelope spike journal June 2016
Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens journal October 2007
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers journal May 2014
Dissociation of gp120 from HIV-1 virions induced by soluble CD4 journal November 1990
Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41 journal November 2013
Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1 journal February 2006
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene journal January 2015
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5 journal December 2012
Rapid evolution of the neutralizing antibody response to HIV type 1 infection journal March 2003
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies journal October 2010
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
Phenotypic properties of transmitted founder HIV-1 journal March 2013
Antibody neutralization and escape by HIV-1 journal March 2003
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer journal October 2013
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield journal October 2011
Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein journal June 2015
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer journal March 2016
Antigenic conservation and immunogenicity of the HIV coreceptor binding site journal May 2005
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies journal November 2009
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability journal June 2016
Identification of Subtype B, Multiple Circulating Recombinant Forms and Unique Recombinants of HIV Type 1 in an MSM Cohort in China journal October 2008
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120 journal July 2012
A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies journal May 2012
Core Structure of gp41 from the HIV Envelope Glycoprotein journal April 1997
Crystal Structure of HIV-1 Primary Receptor CD4 in Complex with a Potent Antiviral Antibody journal December 2010
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry journal November 1998
Random Forests journal January 2001
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure journal December 2014
Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1 journal February 2004
Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies journal January 2014
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 journal April 1998

Cited By (6)

Structural basis of coreceptor recognition by HIV-1 envelope spike journal December 2018
Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11 journal April 2018
Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time journal October 2017
HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions journal July 2018
Cryo-EM Structure of Full-length HIV-1 Env Bound With the Fab of Antibody PG16 journal February 2020
Neutralization tiers of HIV-1 journal January 2018